162 related articles for article (PubMed ID: 22433286)
21. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
Vongsuvanh R; George J; McLeod D; van der Poorten D
J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
[TBL] [Abstract][Full Text] [Related]
22. Body composition analysis by dual energy x-ray absorptiometry and anthropometry in adults with childhood-onset growth hormone (GH) deficiency before and after six months of recombinant GH therapy.
Sartorio A; Narici M; Conti A; Giambona S; Ortolani S; Faglia G
J Endocrinol Invest; 1997; 20(7):417-23. PubMed ID: 9309541
[TBL] [Abstract][Full Text] [Related]
23. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
24. GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner.
Sarmento-Cabral A; Del Rio-Moreno M; Vazquez-Borrego MC; Mahmood M; Gutierrez-Casado E; Pelke N; Guzman G; Subbaiah PV; Cordoba-Chacon J; Yakar S; Kineman RD
J Endocrinol; 2021 Jan; 248(1):31-44. PubMed ID: 33112796
[TBL] [Abstract][Full Text] [Related]
25. Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth.
Silveira LS; Monteiro PA; Antunes Bde M; Seraphim PM; Fernandes RA; Christofaro DG; Freitas Júnior IF
BMC Pediatr; 2013 Aug; 13():115. PubMed ID: 23919592
[TBL] [Abstract][Full Text] [Related]
26. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial.
Hallsworth K; Thoma C; Hollingsworth KG; Cassidy S; Anstee QM; Day CP; Trenell MI
Clin Sci (Lond); 2015 Dec; 129(12):1097-105. PubMed ID: 26265792
[TBL] [Abstract][Full Text] [Related]
27. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.
Dichtel LE; Corey KE; Haines MS; Chicote ML; Kimball A; Colling C; Simon TG; Long MT; Husseini J; Bredella MA; Miller KK
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3624-e3632. PubMed ID: 35779256
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.
Miller KK; Wexler T; Fazeli P; Gunnell L; Graham GJ; Beauregard C; Hemphill L; Nachtigall L; Loeffler J; Swearingen B; Biller BM; Klibanski A
J Clin Endocrinol Metab; 2010 Feb; 95(2):567-77. PubMed ID: 20061426
[TBL] [Abstract][Full Text] [Related]
29. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
Bacchi E; Negri C; Targher G; Faccioli N; Lanza M; Zoppini G; Zanolin E; Schena F; Bonora E; Moghetti P
Hepatology; 2013 Oct; 58(4):1287-95. PubMed ID: 23504926
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism.
Bianchi A; Giampietro A; Tartaglione L; Chiloiro S; Gentilella R; Bima C; Anile C; Olivi A; Pontecorvi A; De Marinis L
J Neuroendocrinol; 2019 Apr; 31(4):e12692. PubMed ID: 30712287
[TBL] [Abstract][Full Text] [Related]
31. Association of pericardial fat with liver fat and insulin sensitivity after diet-induced weight loss in overweight women.
Bosy-Westphal A; Kossel E; Goele K; Blöcker T; Lagerpusch M; Later W; Heller M; Glüer CC; Müller MJ
Obesity (Silver Spring); 2010 Nov; 18(11):2111-7. PubMed ID: 20224561
[TBL] [Abstract][Full Text] [Related]
32. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
[TBL] [Abstract][Full Text] [Related]
33. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency.
Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL
Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients.
Mormando M; Chiloiro S; Bianchi A; Giampietro A; Angelini F; Tartaglione L; Nasto L; Milardi D; Formenti AM; Giustina A; De Marinis L
Clin Endocrinol (Oxf); 2016 Nov; 85(5):717-724. PubMed ID: 27437620
[TBL] [Abstract][Full Text] [Related]
35. SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults.
Glad CA; Barbosa EJ; Filipsson Nyström H; Carlsson LM; Nilsson S; Nilsson AG; Svensson PA; Johannsson G
Eur J Endocrinol; 2014 Jan; 170(1):101-7. PubMed ID: 24114431
[TBL] [Abstract][Full Text] [Related]
36. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
Fishbein MH; Mogren C; Gleason T; Stevens WR
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259
[TBL] [Abstract][Full Text] [Related]
37. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
[TBL] [Abstract][Full Text] [Related]
38. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.
Adetunji OR; MacFarlane IA; Javadpour M; Alfirevic A; Pirmohamed M; Blair JC
Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543
[TBL] [Abstract][Full Text] [Related]
39. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
[TBL] [Abstract][Full Text] [Related]
40. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
